GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (MIL:1QGEN) » Definitions » E10

Qiagen NV (MIL:1QGEN) E10 : €0.97 (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Qiagen NV E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Qiagen NV's adjusted earnings per share data for the three months ended in Sep. 2024 was €0.396. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.97 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Qiagen NV's average E10 Growth Rate was -0.90% per year. During the past 3 years, the average E10 Growth Rate was 24.50% per year. During the past 5 years, the average E10 Growth Rate was 17.70% per year. During the past 10 years, the average E10 Growth Rate was 6.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Qiagen NV was 26.40% per year. The lowest was -3.90% per year. And the median was 10.70% per year.

As of today (2024-12-11), Qiagen NV's current stock price is €41.575. Qiagen NV's E10 for the quarter that ended in Sep. 2024 was €0.97. Qiagen NV's Shiller PE Ratio of today is 42.86.

During the past 13 years, the highest Shiller PE Ratio of Qiagen NV was 115.17. The lowest was 34.79. And the median was 58.15.


Qiagen NV E10 Historical Data

The historical data trend for Qiagen NV's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV E10 Chart

Qiagen NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.97

Qiagen NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.97 1.02 0.97 0.97

Competitive Comparison of Qiagen NV's E10

For the Diagnostics & Research subindustry, Qiagen NV's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qiagen NV's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Qiagen NV's Shiller PE Ratio falls into.



Qiagen NV E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Qiagen NV's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.396/131.6100*131.6100
=0.396

Current CPI (Sep. 2024) = 131.6100.

Qiagen NV Quarterly Data

per share eps CPI Adj_EPS
201412 0.096 99.050 0.128
201503 0.079 99.750 0.104
201506 0.105 100.230 0.138
201509 0.134 100.500 0.175
201512 0.197 99.730 0.260
201603 0.065 100.310 0.085
201606 0.083 100.260 0.109
201609 0.138 100.570 0.181
201612 0.037 100.710 0.048
201703 0.077 101.440 0.100
201706 0.055 101.370 0.071
201709 0.182 102.030 0.235
201712 -0.157 101.970 -0.203
201803 0.117 102.470 0.150
201806 0.141 103.100 0.180
201809 0.230 103.950 0.291
201812 0.236 103.970 0.299
201903 0.119 105.370 0.149
201906 0.173 105.840 0.215
201909 -0.665 106.700 -0.820
201912 0.176 106.800 0.217
202003 0.159 106.850 0.196
202006 0.348 107.510 0.426
202009 0.061 107.880 0.074
202012 0.771 107.850 0.941
202103 0.485 108.870 0.586
202106 0.445 109.670 0.534
202109 0.499 110.790 0.593
202112 0.511 114.010 0.590
202203 0.627 119.460 0.691
202206 0.410 119.050 0.453
202209 0.375 126.890 0.389
202212 0.380 124.940 0.400
202303 0.346 124.720 0.365
202306 0.323 125.830 0.338
202309 0.319 127.160 0.330
202312 0.397 126.450 0.413
202403 0.335 128.580 0.343
202406 -0.771 129.910 -0.781
202409 0.396 131.610 0.396

Add all the adjusted EPS together and divide 10 will get our e10.


Qiagen NV  (MIL:1QGEN) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Qiagen NV's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=41.575/0.97
=42.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Qiagen NV was 115.17. The lowest was 34.79. And the median was 58.15.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Qiagen NV E10 Related Terms

Thank you for viewing the detailed overview of Qiagen NV's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Qiagen NV Business Description

Address
Hulsterweg 82, Venlo, LI, NLD, 5912 PL
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).

Qiagen NV Headlines

No Headlines